Urinary Incontinence Devices Market - Global Forecast To 2030
商品番号 : SMB-74975
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
| ページ数 | 291 |
| 図表数 | 338 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global Urinary incontinence devices market is projected to reach USD 7.97 billion by 2030 from USD 4.22 billion in 2024, at a CAGR of 11.2% during the forecast period.
世界の尿失禁デバイス市場は、予測期間中に11.2%のCAGRで成長し、2024年の42億2,000万米ドルから2030年には79億7,000万米ドルに達すると予測されています。
This is due to growing attention to personal hygiene and advancements in home healthcare solutions. Additionally, rapid urbanization and rising disposable income, consequently increasing the demand for the urinary incontinence devices. However, the potential side-effects & complications by using urinary incontinence devices such as catheters are the major restraint to the market. Additionally, the use of alternative treatment options to treat urinary icnotinence is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.
これは、個人の衛生への関心の高まりと在宅医療ソリューションの進歩によるものです。さらに、急速な都市化と可処分所得の増加により、尿失禁デバイスの需要が増加しています。ただし、カテーテルなどの尿失禁デバイスの使用による潜在的な副作用と合併症は、市場にとって大きな制約となっています。さらに、尿失禁を治療するための代替治療オプションの使用は、市場の成長にとって大きな課題です。しかし、2024年から2030年の予測期間にわたって市場拡大につながる環境を作り出しています。
“The stress incontinence segment of urinary incontinence devices market by incontinence type to hold largest position forecast period.”
Based on the incontinence type, the urinary incontinence devices market is divided into stress incontinence, urge incontinence, mixed incontinence, overflow incontinence, and functional incontinence. Among these, in 2023 stress incontinence segment account for the largest market share of XX% in urinary incontinence devices market. Factors driving the growth of stress incontinence segment include rising aging population, which increases the prevalence of pelvic floor dysfunction, particularly among postmenopausal women. The growing prevalence of stress incontinence is driving demand for urinary incontinence devices, including urinary catheters, vaginal & urethral slings, artificial urinary sphincters, electrical stimulation devices are among the others. According to National Center for Biotechnology Information (NCBI), stress urinary incontinence (SUI) is the most reported type, accounting for 37.5% of cases. This significant prevalence highlights the growing demand for urinary incontinence devices.
“The female patients segment accounts for the largest market share in urinary incontinence devices market.”
Based on patient type, the urinary incontinence devices market is segmented into male patients and female patients. The female patients segment accounts for the largest market share in urinary incontinence devices market. Women are more prone to incontinence than men, owing to factors such as pregnancy, childbirth, and menopause. During each of these events, women can face bladder control issues. Pregnancy can be a short-term cause of incontinence and bladder control issues. Some women experience incontinence after delivery because of the strain childbirth takes on the pelvic floor muscles. During menopause, the decreasing level of estrogen affects bladder control. However, the prevalence of incontinence is known to increase with age, with up to 75% of women above 65 years reporting an episode of incontinence such as urine leakage, further strengthens market demand for urinary incontinence devices among this segment.
“North America accounted for the second largest share of the urinary incontinence devices market by region.”
The global urinary incontinence devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Urinary incontinence devices market in North America is the second-largest regional market. This is due to the growing geriatric population along with rising prevalence of urinary incontinence as well as rapid advancement of healthcare infrastructure. The industry has long been established in the area, with high early-stage support and adoption by clinicians for research and emerging technologies. It is characterized by significant market penetration of urinary incontinence devices among key end users. However, the population of North America was approximately 375 million in 2023, with 66.8 million people aged 65 and above, a demographic that is particularly at risk of urinary incontinence. Such factors create a favorable environment for the growth of the urinary incontinence devices market in this region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
- By Designation: C-level–27%, Director-level–18% and Others–55%
- By Region: Europe–35%, North America–30%, Asia Pacific–22%, Latin America- 10%, and Middle east and Africa – 3%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the urinary incontinence devices market are Coloplast Corp (Denmark), B. Braun SE (Germany), Johnson & Johnson Services, Inc. (US), Convatec Inc. (UK), Boston Scientific Corporation (US), Hollister Incorporated (US), Becton, Dickinson and Company (BD) (US), Cook Group (US), Cardinal Health (US), Laborie (US), Medtronic (Ireland), and Teleflex Incorporated (US).
Research Coverage
This report studies the urinary incontinence devices market based on product, incontinence type, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers (Rising prevalence of urinary incontinence, Expanding geriatric population, Growing attention to personal hygiene, and Advancements in home healthcare solutions), restraints (Social stigma associate with incontinence care products, Environmental concerns related to disposal of urinary incontinence products, and Potential side-effects & complications), Challenge (Use of alternative treatment options), opportunity (Technological advancements in urinary incontinence devices and Rapid urbanization and rising disposable income)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the urinary incontinence devices market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches & product approvals in the urinary incontinence devices market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the urinary incontinence devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 MARKETS COVERED & REGIONS CONSIDERED 28
1.3.2 INCLUSIONS & EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key sources for secondary data 32
2.1.1.2 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Key industry insights 36
2.1.2.4 Breakdown of primary interviews 36
2.2 MARKET SIZE ESTIMATION 37
2.2.1 BOTTOM-UP APPROACH 37
2.2.1.1 Company revenue estimation approach 38
2.2.1.1.1 Presentations of companies and primary interviews 38
2.2.1.1.2 Primary interviews 39
2.2.1.1.3 US-based approach 39
2.2.2 TOP-DOWN APPROACH 41
2.3 DATA TRIANGULATION 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS 43
2.5.1 STUDY ASSUMPTIONS 43
2.5.2 GROWTH RATE ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
2.6.2 SCOPE-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 URINARY INCONTINENCE DEVICES MARKET OVERVIEW 49
4.2 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET,
BY PRODUCT & COUNTRY (2023) 50
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES 51
4.4 REGIONAL MIX: URINARY INCONTINENCE DEVICES MARKET, 2024 VS. 2030 52
4.5 URINARY INCONTINENCE DEVICES MARKET: DEVELOPED VS. EMERGING MARKETS 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Rising prevalence of urinary incontinence 55
5.2.1.2 Expanding geriatric population 56
5.2.1.3 Growing attention to personal hygiene 56
5.2.1.4 Advancements in home healthcare solutions 57
5.2.2 RESTRAINTS 58
5.2.2.1 Social stigma associated with incontinence care products 58
5.2.2.2 Environmental concerns related to disposal of urinary
incontinence products 58
5.2.2.3 Potential side-effects & complications 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Technological advancements in urinary incontinence devices 59
5.2.3.2 Rapid urbanization and rising disposable income 60
5.2.4 CHALLENGES 61
5.2.4.1 Use of alternative treatment options 61
5.3 PRICING ANALYSIS 61
5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 61
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 62
5.4 VALUE CHAIN ANALYSIS 63
5.5 SUPPLY CHAIN ANALYSIS 64
5.6 ECOSYSTEM ANALYSIS 65
5.7 PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 THREAT OF NEW ENTRANTS 68
5.7.2 THREAT OF SUBSTITUTES 69
5.7.3 BARGAINING POWER OF BUYERS 69
5.7.4 BARGAINING POWER OF SUPPLIERS 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 69
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
5.8.2 KEY BUYING CRITERIA 70
5.9 REGULATORY LANDSCAPE 71
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
5.9.2 REGULATORY FRAMEWORK 73
5.9.2.1 North America 73
5.9.2.1.1 US 73
5.9.2.1.2 Canada 74
5.9.2.2 Europe 75
5.9.2.3 Asia Pacific 75
5.9.2.3.1 China 75
5.9.2.3.2 Japan 75
5.9.2.3.3 India 75
5.9.2.4 Latin America 75
5.9.2.4.1 Brazil 76
5.9.2.4.2 Mexico 76
5.9.2.5 Middle East 76
5.9.2.6 Africa 76
5.10 TRADE ANALYSIS 77
5.10.1 IMPORT DATA FOR HS CODE 901839 77
5.10.2 EXPORT DATA FOR HS CODE 901839 77
5.11 PATENT ANALYSIS 78
5.11.1 LIST OF MAJOR PATENTS 79
5.12 KEY CONFERENCES & EVENTS, 2025–2026 79
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.14 TECHNOLOGY ANALYSIS 82
5.14.1 KEY TECHNOLOGIES 82
5.14.1.1 Surgical & implantable devices 82
5.14.2 COMPLEMENTARY TECHNOLOGIES 83
5.14.2.1 Electrical stimulation devices 83
5.15 INVESTMENT & FUNDING SCENARIO 83
5.16 IMPACT OF AI/GEN AI ON URINARY INCONTINENCE DEVICES MARKET 84
5.16.1 AI USE CASES 84
6 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT 85
6.1 INTRODUCTION 86
6.2 URINARY CATHETERS 86
6.2.1 INTERMITTENT CATHETERS 89
6.2.1.1 Reduced risk of infections to boost market 89
6.2.2 INDWELLING CATHETERS 92
6.2.2.1 Rising usage by critically ill patients to drive demand 92
6.2.3 EXTERNAL CATHETERS 94
6.2.3.1 Ease of use to boost market growth 94
6.3 VAGINAL & URETHRAL SLINGS 97
6.3.1 RISING PREVALENCE OF STRESS INCONTINENCE TO DRIVE GROWTH 97
6.4 ELECTRICAL STIMULATION DEVICES 99
6.4.1 GROWING PREFERENCE FOR ELECTRICAL STIMULATION DEVICES FOR TREATMENT OF OAB TO DRIVE GROWTH 99
6.5 ARTIFICIAL URINARY SPHINCTERS 102
6.5.1 REDUCED RISK OF INFECTIONS ASSOCIATED WITH ARTIFICIAL
URINARY SPHINCTERS TO DRIVE ADOPTION 102
6.6 OTHER URINARY INCONTINENCE DEVICES 105
7 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE 109
7.1 INTRODUCTION 110
7.2 STRESS INCONTINENCE 110
7.2.1 GROWING PREVALENCE OF STRESS INCONTINENCE TO
DRIVE MARKET GROWTH 110
7.3 URGE INCONTINENCE 114
7.3.1 CONTINUOUS INNOVATIONS TO SUSTAIN MARKET GROWTH 114
7.4 MIXED INCONTINENCE 117
7.4.1 GROWING AWARENESS AMONG BOTH PATIENTS AND HEALTHCARE PROVIDERS TO BOOST MARKET GROWTH 117
7.5 OVERFLOW INCONTINENCE 120
7.5.1 AGING POPULATION AND ASSOCIATED UROLOGICAL CONDITIONS TO
DRIVE MARKET DEMAND 120
7.6 FUNCTIONAL INCONTINENCE 123
7.6.1 MOBILITY DISORDERS TO SUSTAIN MARKET GROWTH 123
8 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE 127
8.1 INTRODUCTION 128
8.2 FEMALE PATIENTS 128
8.2.1 HIGHER RATE OF URINARY INCONTINENCE IN FEMALES TO DRIVE MARKET 128
8.3 MALE PATIENTS 131
8.3.1 RISING PREVALENCE OF BPH TO PROPEL MARKET GROWTH 131
9 URINARY INCONTINENCE DEVICES MARKET, BY END USER 135
9.1 INTRODUCTION 136
9.2 HOSPITALS 136
9.2.1 LARGE VOLUME OF SURGICAL PROCEDURES TO DRIVE GROWTH 136
9.3 PHYSICIANS’ OFFICES 139
9.3.1 EXPERTISE OF PROFESSIONALS IN TREATMENT OF URINARY INCONTINENCE TO PROPEL GROWTH 139
9.4 OTHER END USERS 141
10 URINARY INCONTINENCE DEVICES MARKET, BY REGION 145
10.1 INTRODUCTION 146
10.2 NORTH AMERICA 146
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 147
10.2.2 US 150
10.2.2.1 Favorable healthcare initiatives for prevention of UI to drive market 150
10.2.3 CANADA 153
10.2.3.1 Increasing geriatric population to drive market growth 153
10.3 EUROPE 156
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158
10.3.2 GERMANY 161
10.3.2.1 Rising healthcare expenditure to propel market 161
10.3.3 UK 164
10.3.3.1 Rising prevalence of chronic diseases to support market growth 164
10.3.4 FRANCE 167
10.3.4.1 Large target population to boost demand 167
10.3.5 ITALY 170
10.3.5.1 Rising geriatric population and subsequent rise in UI to drive market 170
10.3.6 SPAIN 173
10.3.6.1 Uptake of advanced technologies for UI treatment to
support market growth 173
10.3.7 REST OF EUROPE 176
10.4 ASIA PACIFIC 179
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 180
10.4.2 CHINA 184
10.4.2.1 Growing focus on preventive care due to large target patient pool to boost demand 184
10.4.3 JAPAN 187
10.4.3.1 Presence of established healthcare system and favorable reimbursements to drive market 187
10.4.4 INDIA 190
10.4.4.1 Rising cases of urinary incontinence and increasing healthcare investments to propel market 190
10.4.5 REST OF ASIA PACIFIC 193
10.5 LATIN AMERICA 196
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 197
10.5.2 BRAZIL 200
10.5.2.1 Favorable reimbursement scenario for medical device manufacturers to drive market 200
10.5.3 MEXICO 203
10.5.3.1 Rising demand for advanced UI products to drive market 203
10.5.4 REST OF LATIN AMERICA 206
10.6 MIDDLE EAST & AFRICA 209
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT
MARKET GROWTH 209
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 210
11 COMPETITIVE LANDSCAPE 214
11.1 INTRODUCTION 214
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 214
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
URINARY INCONTINENCE DEVICES MARKET 214
11.3 REVENUE ANALYSIS, 2019–2023 216
11.4 MARKET SHARE ANALYSIS, 2023 217
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 219
11.5.1 STARS 219
11.5.2 EMERGING LEADERS 219
11.5.3 PERVASIVE PLAYERS 219
11.5.4 PARTICIPANTS 219
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 221
11.5.5.1 Company footprint 221
11.5.5.2 Region footprint 222
11.5.5.3 Product footprint 223
11.5.5.4 Patient type footprint 224
11.5.5.5 End-user footprint 225
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 225
11.6.1 PROGRESSIVE COMPANIES 225
11.6.2 RESPONSIVE COMPANIES 225
11.6.3 DYNAMIC COMPANIES 226
11.6.4 STARTING BLOCKS 226
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 227
11.6.5.1 Detailed list of key startup/SME players 227
11.6.5.2 Competitive benchmarking of key emerging players/startups 227
11.7 COMPANY VALUATION & FINANCIAL METRICS 228
11.8 BRAND/PRODUCT COMPARISON 229
11.9 COMPETITIVE SCENARIO 230
11.9.1 PRODUCT LAUNCHES & APPROVALS 230
11.9.2 DEALS 231
11.9.3 EXPANSIONS 232
11.9.4 OTHER DEVELOPMENTS 232
12 COMPANY PROFILES 233
12.1 KEY PLAYERS 233
12.1.1 COLOPLAST CORP. 233
12.1.1.1 Business overview 233
12.1.1.2 Products offered 235
12.1.1.3 Recent developments 236
12.1.1.3.1 Product launches 236
12.1.1.3.2 Expansions 236
12.1.1.4 MnM view 237
12.1.1.4.1 Key strengths 237
12.1.1.4.2 Strategic choices 237
12.1.1.4.3 Weaknesses & competitive threats 237
12.1.2 B. BRAUN SE 238
12.1.2.1 Business overview 238
12.1.2.2 Products offered 240
12.1.2.3 MnM view 241
12.1.2.3.1 Key strengths 241
12.1.2.3.2 Strategic choices 241
12.1.2.3.3 Weaknesses & competitive threats 241
12.1.3 JOHNSON & JOHNSON SERVICES, INC. 242
12.1.3.1 Business overview 242
12.1.3.2 Products offered 243
12.1.3.3 MnM view 244
12.1.3.3.1 Key strengths 244
12.1.3.3.2 Strategic choices 244
12.1.3.3.3 Weaknesses & competitive threats 244
12.1.4 CONVATEC INC. 245
12.1.4.1 Business overview 245
12.1.4.2 Products offered 247
12.1.4.3 Recent developments 247
12.1.4.3.1 Product launches 247
12.1.4.3.2 Deals 248
12.1.4.4 MnM view 248
12.1.4.4.1 Key strengths 248
12.1.4.4.2 Strategic choices 248
12.1.4.4.3 Weaknesses & competitive threats 248
12.1.5 BOSTON SCIENTIFIC CORPORATION 249
12.1.5.1 Business overview 249
12.1.5.2 Products offered 251
12.1.5.3 Recent developments 251
12.1.5.3.1 Deals 251
12.1.5.4 MnM view 252
12.1.5.4.1 Key strengths 252
12.1.5.4.2 Strategic choices 252
12.1.5.4.3 Weaknesses & competitive threats 252
12.1.6 MEDTRONIC 253
12.1.6.1 Business overview 253
12.1.6.2 Products offered 254
12.1.6.3 Recent developments 255
12.1.6.3.1 Product approvals 255
12.1.7 TELEFLEX INCORPORATED 256
12.1.7.1 Business overview 256
12.1.7.2 Products offered 258
12.1.8 BECTON, DICKINSON AND COMPANY (BD) 259
12.1.8.1 Business overview 259
12.1.8.2 Products offered 260
12.1.9 CARDINAL HEALTH 261
12.1.9.1 Business overview 261
12.1.9.2 Products offered 263
12.1.10 HOLLISTER INCORPORATED 264
12.1.10.1 Business overview 264
12.1.10.2 Products offered 265
12.1.10.3 Recent developments 265
12.1.10.3.1 Product launches 265
12.1.11 COOK GROUP 266
12.1.11.1 Business overview 266
12.1.11.2 Products offered 266
12.1.12 LABORIE 267
12.1.12.1 Business overview 267
12.1.12.2 Products offered 267
12.1.12.3 Recent developments 268
12.1.12.3.1 Other developments 268
12.2 OTHER PLAYERS 269
12.2.1 WELLSPECT HEALTHCARE 269
12.2.2 CALDERA MEDICAL 270
12.2.3 DYNAREX CORPORATION 271
12.2.4 ADVACARE PHARMA 272
12.2.5 MRK HEALTHCARE PVT. LTD. 273
12.2.6 ADVIN HEALTH CARE 274
12.2.7 CLINIMED LIMITED 275
12.2.8 STERIMED GROUP 276
12.2.9 KIMBERLY-CLARK CORPORATION (KCWW) 277
12.2.10 INCONTROL MEDICAL 278
12.2.11 ZEPHYR SURGICAL IMPLANTS 279
12.2.12 FLEXICARE (GROUP) LIMITED 280
12.2.13 STRYKER 281
13 APPENDIX 282
13.1 DISCUSSION GUIDE 282
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287
13.3 CUSTOMIZATION OPTIONS 289
13.4 RELATED REPORTS 289
13.5 AUTHOR DETAILS 290
LIST OF TABLES
TABLE 1 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 35
TABLE 2 URINARY INCONTINENCE DEVICES MARKET: STUDY ASSUMPTIONS 43
TABLE 3 URINARY INCONTINENCE DEVICES MARKET: RISK ASSESSMENT 44
TABLE 4 PREVALENCE OF URINARY INCONTINENCE AMONG OLDER WOMEN, BY REGION 55
TABLE 5 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES,
BY KEY PLAYER, 2022–2024 62
TABLE 6 AVERAGE SELLING PRICE TREND OF URINARY INCONTINENCE DEVICES,
BY REGION, 2021–2023 62
TABLE 7 URINARY INCONTINENCE DEVICES MARKET: ROLE IN ECOSYSTEM 66
TABLE 8 URINARY INCONTINENCE DEVICES MARKET: PORTER’S FIVE FORCES 67
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 70
TABLE 10 KEY BUYING CRITERIA FOR MAJOR END USERS 71
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 16 US FDA: MEDICAL DEVICE CLASSIFICATION 74
TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 74
TABLE 18 IMPORT DATA FOR HS CODE 901839, BY COUNTRY,
2020–2024 (USD THOUSAND) 77
TABLE 19 EXPORT DATA FOR HS CODE 901839, BY COUNTRY,
2020–2024 (USD THOUSAND) 77
TABLE 20 URINARY INCONTINENCE DEVICES MARKET: LIST OF MAJOR PATENTS 79
TABLE 21 URINARY INCONTINENCE DEVICES MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 80
TABLE 22 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 86
TABLE 23 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY REGION, 2022–2030 (USD MILLION) 87
TABLE 24 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR
URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 87
TABLE 25 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 88
TABLE 26 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 88
TABLE 27 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 89
TABLE 28 URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 89
TABLE 29 URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS,
BY REGION, 2022–2030 (USD MILLION) 90
TABLE 30 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 90
TABLE 31 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 32 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 33 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INTERMITTENT CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 92
TABLE 34 URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS,
BY REGION, 2022–2030 (USD MILLION) 92
TABLE 35 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 93
TABLE 36 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 93
TABLE 37 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 94
TABLE 38 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR INDWELLING CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 94
TABLE 39 URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS,
BY REGION, 2022–2030 (USD MILLION) 95
TABLE 40 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 95
TABLE 41 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 96
TABLE 42 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 96
TABLE 43 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR EXTERNAL CATHETERS, BY COUNTRY, 2022–2030 (USD MILLION) 97
TABLE 44 URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS,
BY REGION, 2022–2030 (USD MILLION) 97
TABLE 45 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 46 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 47 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 99
TABLE 48 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR VAGINAL & URETHRAL SLINGS, BY COUNTRY, 2022–2030 (USD MILLION) 99
TABLE 49 URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2022–2030 (USD MILLION) 100
TABLE 50 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 100
TABLE 51 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 101
TABLE 52 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 101
TABLE 53 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2022–2030 (USD MILLION) 102
TABLE 54 URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2022–2030 (USD MILLION) 103
TABLE 55 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 103
TABLE 56 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 104
TABLE 57 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 104
TABLE 58 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 59 OTHER URINARY INCONTINENCE DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 106
TABLE 60 NORTH AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 106
TABLE 61 EUROPE: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 107
TABLE 62 ASIA PACIFIC: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107
TABLE 63 LATIN AMERICA: OTHER URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 108
TABLE 64 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE,
2022–2030 (USD MILLION) 110
TABLE 65 KEY PRODUCTS FOR TREATMENT OF STRESS INCONTINENCE 111
TABLE 66 URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE,
BY REGION, 2022–2030 (USD MILLION) 112
TABLE 67 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 112
TABLE 68 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 69 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 70 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR STRESS INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 71 URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE,
BY REGION, 2022–2030 (USD MILLION) 115
TABLE 72 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 73 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 74 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR
URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 75 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URGE INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 76 URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE,
BY REGION, 2022–2030 (USD MILLION) 118
TABLE 77 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 118
TABLE 78 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 79 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 80 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MIXED INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 81 URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE,
BY REGION, 2022–2030 (USD MILLION) 121
TABLE 82 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 83 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 84 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 85 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OVERFLOW INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 86 URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE,
BY REGION, 2022–2030 (USD MILLION) 124
TABLE 87 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 124
TABLE 88 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 89 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 90 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FUNCTIONAL INCONTINENCE, BY COUNTRY, 2022–2030 (USD MILLION) 126
TABLE 91 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 128
TABLE 92 URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 129
TABLE 93 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 94 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 130
TABLE 95 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 130
TABLE 96 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 131
TABLE 97 URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 132
TABLE 98 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 132
TABLE 99 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 100 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 101 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 134
TABLE 102 URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 136
TABLE 103 URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS, BY REGION,
2022–2030 (USD MILLION) 137
TABLE 104 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 137
TABLE 105 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 138
TABLE 106 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 138
TABLE 107 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 108 URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES,
BY REGION, 2022–2030 (USD MILLION) 139
TABLE 109 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 140
TABLE 110 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 140
TABLE 111 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 141
TABLE 112 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR PHYSICIANS’ OFFICES, BY COUNTRY, 2022–2030 (USD MILLION) 141
TABLE 113 URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 142
TABLE 114 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 142
TABLE 115 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2030 (USD MILLION) 143
TABLE 116 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 143
TABLE 117 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 144
TABLE 118 URINARY INCONTINENCE DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 146
TABLE 119 NORTH AMERICA: MACROECONOMIC INDICATORS 147
TABLE 120 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 147
TABLE 121 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 148
TABLE 122 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 148
TABLE 123 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 149
TABLE 124 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 149
TABLE 125 NORTH AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 149
TABLE 126 US: NUMBER OF INDWELLING/FOLEY CATHETERS SOLD IN US (MILLION) 150
TABLE 127 US: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 151
TABLE 128 US: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 151
TABLE 129 US: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE,
2022–2030 (USD MILLION) 152
TABLE 130 US: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 152
TABLE 131 US: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 153
TABLE 132 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 154
TABLE 133 CANADA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 154
TABLE 134 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 155
TABLE 135 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 155
TABLE 136 CANADA: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 156
TABLE 137 EUROPE: MACROECONOMIC INDICATORS 158
TABLE 138 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 158
TABLE 139 EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 159
TABLE 140 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 159
TABLE 141 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 160
TABLE 142 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 160
TABLE 143 EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 161
TABLE 144 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 162
TABLE 145 GERMANY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 162
TABLE 146 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 163
TABLE 147 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 163
TABLE 148 GERMANY: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 164
TABLE 149 UK: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 165
TABLE 150 UK: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 165
TABLE 151 UK: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE,
2022–2030 (USD MILLION) 166
TABLE 152 UK: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 166
TABLE 153 UK: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 167
TABLE 154 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 168
TABLE 155 FRANCE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 168
TABLE 156 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 169
TABLE 157 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 169
TABLE 158 FRANCE: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 170
TABLE 159 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 171
TABLE 160 ITALY: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 171
TABLE 161 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 172
TABLE 162 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 172
TABLE 163 ITALY: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 173
TABLE 164 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 174
TABLE 165 SPAIN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 174
TABLE 166 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 175
TABLE 167 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 175
TABLE 168 SPAIN: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 176
TABLE 169 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 177
TABLE 170 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 177
TABLE 171 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 178
TABLE 172 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 178
TABLE 173 REST OF EUROPE: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 179
TABLE 174 ASIA PACIFIC: MACROECONOMIC INDICATORS 180
TABLE 175 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 182
TABLE 176 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 182
TABLE 177 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 183
TABLE 178 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 183
TABLE 179 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 184
TABLE 180 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 184
TABLE 181 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 185
TABLE 182 CHINA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 186
TABLE 183 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 186
TABLE 184 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 187
TABLE 185 CHINA: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 187
TABLE 186 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 188
TABLE 187 JAPAN: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 189
TABLE 188 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 189
TABLE 189 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 190
TABLE 190 JAPAN: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 190
TABLE 191 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 191
TABLE 192 INDIA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 192
TABLE 193 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 192
TABLE 194 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 193
TABLE 195 INDIA: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 193
TABLE 196 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 194
TABLE 197 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 198 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET,
BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 195
TABLE 199 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET,
BY PATIENT TYPE, 2022–2030 (USD MILLION) 196
TABLE 200 REST OF ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 196
TABLE 201 LATIN AMERICA: MACROECONOMIC INDICATORS 197
TABLE 202 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 198
TABLE 203 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 198
TABLE 204 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 199
TABLE 205 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 199
TABLE 206 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 200
TABLE 207 LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 200
TABLE 208 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 201
TABLE 209 BRAZIL: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS,
BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 210 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 202
TABLE 211 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 202
TABLE 212 BRAZIL: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 203
TABLE 213 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 204
TABLE 214 MEXICO: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 215 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 205
TABLE 216 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 205
TABLE 217 MEXICO: URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 206
TABLE 218 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 207
TABLE 219 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 207
TABLE 220 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET,
BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 208
TABLE 221 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET,
BY PATIENT TYPE, 2022–2030 (USD MILLION) 208
TABLE 222 REST OF LATIN AMERICA: URINARY INCONTINENCE DEVICES MARKET,
BY END USER, 2022–2030 (USD MILLION) 209
TABLE 223 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 210
TABLE 224 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 211
TABLE 225 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET FOR URINARY CATHETERS, BY TYPE, 2022–2030 (USD MILLION) 211
TABLE 226 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET,
BY INCONTINENCE TYPE, 2022–2030 (USD MILLION) 212
TABLE 227 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET,
BY PATIENT TYPE, 2022–2030 (USD MILLION) 212
TABLE 228 MIDDLE EAST & AFRICA: URINARY INCONTINENCE DEVICES MARKET,
BY END USER, 2022–2030 (USD MILLION) 213
TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET 214
TABLE 230 URINARY INCONTINENCE DEVICES MARKET: DEGREE OF COMPETITION 217
TABLE 231 URINARY INCONTINENCE DEVICES MARKET: REGION FOOTPRINT 222
TABLE 232 URINARY INCONTINENCE DEVICES MARKET: PRODUCT FOOTPRINT 223
TABLE 233 URINARY INCONTINENCE DEVICES MARKET: PATIENT TYPE FOOTPRINT 224
TABLE 234 URINARY INCONTINENCE DEVICES MARKET: END-USER FOOTPRINT 225
TABLE 235 URINARY INCONTINENCE DEVICES MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS 227
TABLE 236 URINARY INCONTINENCE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 227
TABLE 237 URINARY INCONTINENCE DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 230
TABLE 238 URINARY INCONTINENCE DEVICES MARKET: DEALS,
JANUARY 2021–JANUARY 2025 231
TABLE 239 URINARY INCONTINENCE DEVICES MARKET: EXPANSIONS,
JANUARY 2021–JANUARY 2025 232
TABLE 240 URINARY INCONTINENCE DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–JANUARY 2025 232
TABLE 241 COLOPLAST CORP.: COMPANY OVERVIEW 233
TABLE 242 EXCHANGE RATES USED FOR CONVERSION OF DKK TO USD 234
TABLE 243 COLOPLAST CORP.: PRODUCTS OFFERED 235
TABLE 244 COLOPLAST CORP.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 236
TABLE 245 COLOPLAST CORP.: EXPANSIONS, JANUARY 2021–JANUARY 2025 236
TABLE 246 B. BRAUN SE: COMPANY OVERVIEW 238
TABLE 247 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD 239
TABLE 248 B. BRAUN SE: PRODUCTS OFFERED 240
TABLE 249 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 242
TABLE 250 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 243
TABLE 251 CONVATEC INC.: COMPANY OVERVIEW 245
TABLE 252 CONVATEC INC.: PRODUCTS OFFERED 247
TABLE 253 CONVATEC INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 247
TABLE 254 CONVATEC INC.: DEALS, JANUARY 2021– JANUARY 2025 248
TABLE 255 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 249
TABLE 256 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 251
TABLE 257 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021– JANUARY 2025 251
TABLE 258 MEDTRONIC: COMPANY OVERVIEW 253
TABLE 259 MEDTRONIC: PRODUCTS OFFERED 254
TABLE 260 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 255
TABLE 261 TELEFLEX INCORPORATED: COMPANY OVERVIEW 256
TABLE 262 TELEFLEX INCORPORATED: PRODUCTS OFFERED 258
TABLE 263 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 259
TABLE 264 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 260
TABLE 265 CARDINAL HEALTH: COMPANY OVERVIEW 261
TABLE 266 CARDINAL HEALTH: PRODUCTS OFFERED 263
TABLE 267 HOLLISTER INCORPORATED: COMPANY OVERVIEW 264
TABLE 268 HOLLISTER INCORPORATED: PRODUCTS OFFERED 265
TABLE 269 HOLLISTER INCORPORATED: PRODUCT LAUNCHES,
JANUARY 2021–JANUARY 2025 265
TABLE 270 COOK GROUP: COMPANY OVERVIEW 266
TABLE 271 COOK GROUP: PRODUCTS OFFERED 266
TABLE 272 LABORIE: COMPANY OVERVIEW 267
TABLE 273 LABORIE: PRODUCTS OFFERED 267
TABLE 274 LABORIE: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 268
TABLE 275 WELLSPECT HEALTHCARE: COMPANY OVERVIEW 269
TABLE 276 CALDERA MEDICAL: COMPANY OVERVIEW 270
TABLE 277 DYNAREX CORPORATION: COMPANY OVERVIEW 271
TABLE 278 ADVACARE PHARMA: COMPANY OVERVIEW 272
TABLE 279 MRK HEALTHCARE PVT. LTD.: COMPANY OVERVIEW 273
TABLE 280 ADVIN HEALTH CARE: COMPANY OVERVIEW 274
TABLE 281 CLINIMED LIMITED: COMPANY OVERVIEW 275
TABLE 282 STERIMED GROUP: COMPANY OVERVIEW 276
TABLE 283 KIMBERLEY-CLARK CORPORATION (KCWW): COMPANY OVERVIEW 277
TABLE 284 INCONTROL MEDICAL: COMPANY OVERVIEW 278
TABLE 285 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW 279
TABLE 286 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 280
TABLE 287 STRYKER: COMPANY OVERVIEW 281
LIST OF FIGURES
FIGURE 1 URINARY INCONTINENCE DEVICES MARKET: RESEARCH DESIGN 31
FIGURE 2 URINARY INCONTINENCE DEVICES MARKET: KEY DATA FROM
SECONDARY SOURCES 33
FIGURE 3 URINARY INCONTINENCE DEVICES MARKET: KEY PRIMARY SOURCES 34
FIGURE 4 URINARY INCONTINENCE DEVICES MARKET: KEY INDUSTRY INSIGHTS 36
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 36
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 37
FIGURE 7 URINARY INCONTINENCE DEVICES MARKET: REVENUE SHARE ANALYSIS 38
FIGURE 8 URINARY INCONTINENCE DEVICES MARKET: US-BASED APPROACH 39
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 10 URINARY INCONTINENCE DEVICES MARKET: TOP-DOWN APPROACH 41
FIGURE 11 URINARY INCONTINENCE DEVICES MARKET: DATA TRIANGULATION 42
FIGURE 12 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT,
2024 VS. 2030 (USD MILLION) 45
FIGURE 13 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE,
2024 VS. 2030 (USD MILLION) 46
FIGURE 14 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE,
2024 VS. 2030 (USD MILLION) 46
FIGURE 15 URINARY INCONTINENCE DEVICES MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 47
FIGURE 16 GEOGRAPHIC SNAPSHOT OF URINARY INCONTINENCE DEVICES MARKET 48
FIGURE 17 RISING PREVALENCE OF URINARY INCONTINENCE TO PROPEL MARKET 49
FIGURE 18 URINARY CATHETERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE
IN CHINA IN 2023 50
FIGURE 19 CHINA TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 51
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 52
FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING FORECAST PERIOD 53
FIGURE 22 URINARY INCONTINENCE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
FIGURE 23 URINARY INCONTINENCE DEVICES MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 24 URINARY INCONTINENCE DEVICES MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 25 URINARY INCONTINENCE DEVICES MARKET: ECOSYSTEM ANALYSIS 65
FIGURE 26 KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET ECOSYSTEM 66
FIGURE 27 URINARY INCONTINENCE DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 70
FIGURE 29 KEY BUYING CRITERIA FOR MAJOR END USERS 70
FIGURE 30 PATENT ANALYSIS FOR URINARY INCONTINENCE DEVICES,
JANUARY 1, 2015–DECEMBER 31, 2024 78
FIGURE 31 URINARY INCONTINENCE DEVICES MARKET: TRENDS & DISRUPTIONS
IMPACTING CUSTOMERS’ BUSINESSES 82
FIGURE 32 URINARY INCONTINENCE DEVICES MARKET: INVESTMENT & FUNDING SCENARIO 83
FIGURE 33 EUROPE: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT 157
FIGURE 34 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET SNAPSHOT 181
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET (2019–2023) 216
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINARY INCONTINENCE
DEVICES MARKET (2023) 217
FIGURE 37 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 220
FIGURE 38 URINARY INCONTINENCE DEVICES MARKET: COMPANY FOOTPRINT 221
FIGURE 39 URINARY INCONTINENCE DEVICES MARKET: COMPANY EVALUATION
MATRIX (STARTUPS/SMES), 2023 226
FIGURE 40 EV/EBITDA OF KEY VENDORS, 2023–2024 228
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 228
FIGURE 42 URINARY INCONTINENCE DEVICES MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 229
FIGURE 43 COLOPLAST CORP.: COMPANY SNAPSHOT 234
FIGURE 44 B. BRAUN SE: COMPANY SNAPSHOT 239
FIGURE 45 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 243
FIGURE 46 CONVATEC INC.: COMPANY SNAPSHOT 246
FIGURE 47 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 250
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT 254
FIGURE 49 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 257
FIGURE 50 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 260
FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT 262
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
- 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
- オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
- 建設重機市場 – 2030年までの世界予測 2025-04-03
- 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02